Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 316

Related Citations for PubMed (Select 12060771)

1.

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.

Kelly LM, Kutok JL, Williams IR, Boulton CL, Amaral SM, Curley DP, Ley TJ, Gilliland DG.

Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8283-8.

2.

High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.

Westervelt P, Lane AA, Pollock JL, Oldfather K, Holt MS, Zimonjic DB, Popescu NC, DiPersio JF, Ley TJ.

Blood. 2003 Sep 1;102(5):1857-65. Epub 2003 May 15.

3.

Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model.

Santana BA, Pintão MC, Abreu e Lima RS, Scheucher PS, Santos GA, Garcia AB, Falcão RP, Rego EM.

Braz J Med Biol Res. 2006 May;39(5):615-20. Epub 2006 Apr 20.

5.

Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.

Zheng X, Seshire A, Rüster B, Bug G, Beissert T, Puccetti E, Hoelzer D, Henschler R, Ruthardt M.

Haematologica. 2007 Mar;92(3):323-31.

6.

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.

He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5302-7.

7.

Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.

Agrawal-Singh S, Koschmieder S, Gelsing S, Stocking C, Stehling M, Thiede C, Thoennissen NH, Köhler G, Valk PJ, Delwel R, Mills K, Bäumer N, Tickenbrock L, Hansen K, Berdel WE, Müller-Tidow C, Serve H.

Blood. 2010 Jun 3;115(22):4507-16. doi: 10.1182/blood-2009-03-210070. Epub 2010 Mar 9.

8.

A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.

Sohal J, Phan VT, Chan PV, Davis EM, Patel B, Kelly LM, Abrams TJ, O'Farrell AM, Gilliland DG, Le Beau MM, Kogan SC.

Blood. 2003 Apr 15;101(8):3188-97. Epub 2002 Dec 19.

9.

Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.

Zimonjic DB, Pollock JL, Westervelt P, Popescu NC, Ley TJ.

Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13306-11.

10.
11.

Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.

Rusiniak ME, Yu M, Ross DT, Tolhurst EC, Slack JL.

Cancer Res. 2000 Apr 1;60(7):1824-9.

13.

Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.

Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP.

Oncogene. 2006 Mar 23;25(13):1974-9.

PMID:
16331271
14.

Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.

Shih LY, Kuo MC, Liang DC, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Lai CL.

Cancer. 2003 Sep 15;98(6):1206-16.

15.

Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha.

Sukhai MA, Wu X, Xuan Y, Zhang T, Reis PP, Dubé K, Rego EM, Bhaumik M, Bailey DJ, Wells RA, Kamel-Reid S, Pandolfi PP.

Oncogene. 2004 Jan 22;23(3):665-78.

PMID:
14737102
16.

UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia.

Kitareewan S, Pitha-Rowe I, Sekula D, Lowrey CH, Nemeth MJ, Golub TR, Freemantle SJ, Dmitrovsky E.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3806-11. Epub 2002 Mar 12.

17.
18.

Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.

Cheng GX, Zhu XH, Men XQ, Wang L, Huang QH, Jin XL, Xiong SM, Zhu J, Guo WM, Chen JQ, Xu SF, So E, Chan LC, Waxman S, Zelent A, Chen GQ, Dong S, Liu JX, Chen SJ.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6318-23.

19.

Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.

Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tsuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Iinuma K.

Blood. 1998 Jul 15;92(2):374-82.

20.

Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells.

Côté S, Rosenauer A, Bianchini A, Seiter K, Vandewiele J, Nervi C, Miller WH Jr.

Blood. 2002 Oct 1;100(7):2586-96.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk